Remedika LTD

The drug is prescribed for the treatment of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN), hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL). It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).

Dosage form: tablets, film-coated

ATC: L01EA01

The drug is used to treat various types of leukemia (chronic myeloid and acute lymphoblastic), myelodysplastic syndrome, hypereosinophilic syndrome, as well as gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma.

Dosage form: tablets, film-coated

ATC: L01EA01

The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), as well as for adjuvant therapy of RCC in patients at high risk of recurrence. It is also used for the treatment of progressive pancreatic neuroendocrine tumors.

Dosage form: capsules, hard

ATC: L01XE04

The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for adult RCC patients at high risk of recurrence after nephrectomy, and for the treatment of progressive pancreatic neuroendocrine tumors.

Dosage form: capsules, hard

ATC: L01XE04

The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC in adults at high risk of recurrence, as well as progressive pancreatic neuroendocrine tumors.

Dosage form: capsules, hard

ATC: L01XE04

The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), as well as adjuvant therapy for RCC in adults at high risk of recurrence after surgery. It is also used for the treatment of progressive pancreatic neuroendocrine tumors.

Dosage form: capsules, hard

ATC: L01XE04